These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18828631)

  • 1. Effects of linker length and flexibility on multivalent targeting.
    Shewmake TA; Solis FJ; Gillies RJ; Caplan MR
    Biomacromolecules; 2008 Nov; 9(11):3057-64. PubMed ID: 18828631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of rigid or flexible linkage between two ligands on the effective affinity and avidity for reversible interactions with bivalent receptors.
    Bobrovnik SA
    J Mol Recognit; 2007; 20(4):253-62. PubMed ID: 17847051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of targeting ligand flexibility on receptor binding of particulate drug delivery systems.
    Olivier V; Meisen I; Meckelein B; Hirst TR; Peter-Katalinic J; Schmidt MA; Frey A
    Bioconjug Chem; 2003; 14(6):1203-8. PubMed ID: 14624636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility.
    Reinke AA; Gestwicki JE
    Chem Biol Drug Des; 2007 Sep; 70(3):206-15. PubMed ID: 17718715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-step synthesis of multivalent cancer-targeting constructs.
    Stukel JM; Li RC; Maynard HD; Caplan MR
    Biomacromolecules; 2010 Jan; 11(1):160-7. PubMed ID: 19924844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicle aggregation by multivalent ligands: relating crosslinking ability to surface affinity.
    Wang X; Mart RJ; Webb SJ
    Org Biomol Chem; 2007 Aug; 5(15):2498-505. PubMed ID: 17637972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting drugs to combinations of receptors: a modeling analysis of potential specificity.
    Caplan MR; Rosca EV
    Ann Biomed Eng; 2005 Aug; 33(8):1113-24. PubMed ID: 16133919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Architectural and structural optimization of the protective polymer layer for enhanced targeting.
    Chen CC; Dormidontova EE
    Langmuir; 2005 Jun; 21(12):5605-15. PubMed ID: 15924497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the multivalent recognition between dendritic molecules and DNA: understanding how ligand "sacrifice" and screening can enhance binding.
    Pavan GM; Danani A; Pricl S; Smith DK
    J Am Chem Soc; 2009 Jul; 131(28):9686-94. PubMed ID: 19555062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic implication for cross-linking in sterculia-based hydrogels and their use in GIT drug delivery.
    Singh B; Sharma N
    Biomacromolecules; 2009 Sep; 10(9):2515-32. PubMed ID: 19708684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing delivery of multivalent targeting constructs for detection of secondary tumors.
    Stukel JM; Heys JJ; Caplan MR
    Ann Biomed Eng; 2008 Jul; 36(7):1291-304. PubMed ID: 18425582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivalent display of quinic acid based ligands for targeting E-selectin expressing cells.
    Shamay Y; Paulin D; Ashkenasy G; David A
    J Med Chem; 2009 Oct; 52(19):5906-15. PubMed ID: 19746918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofunctional coatings via targeted covalent cross-linking of associating triblock proteins.
    Fischer SE; Mi L; Mao HQ; Harden JL
    Biomacromolecules; 2009 Sep; 10(9):2408-17. PubMed ID: 19655714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of integrin alpha(v)beta3-targeting Ab 38C2 constructs.
    Sinha SC; Das S; Li LS; Lerner RA; Barbas CF
    Nat Protoc; 2007; 2(2):449-56. PubMed ID: 17406606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design of polyvalent scaffolds for targeted delivery.
    Vance D; Martin J; Patke S; Kane RS
    Adv Drug Deliv Rev; 2009 Sep; 61(11):931-9. PubMed ID: 19596034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of single-chain antibody affinity with temperature-responsive elastin-like polypeptide linkers.
    Megeed Z; Winters RM; Yarmush ML
    Biomacromolecules; 2006 Apr; 7(4):999-1004. PubMed ID: 16602713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles.
    Wang M; Löwik DW; Miller AD; Thanou M
    Bioconjug Chem; 2009 Jan; 20(1):32-40. PubMed ID: 19099499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalent ligands with long nanometer-scale flexible linkers.
    Tian L; Heyduk T
    Biochemistry; 2009 Jan; 48(2):264-75. PubMed ID: 19113836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of thin and flexible theophylline imprinted polymer membrane materials.
    Hillberg AL; Brain KR; Allender CJ
    J Mol Recognit; 2009; 22(3):223-31. PubMed ID: 19177493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.